Dbv technologies to participate in upcoming investor conference

Montrouge, france, june 06, 2023 db v technologies to participate in upcoming investor conference dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today announced its participation in the goldman sachs 44th annual global healthcare conference taking place on june 12th – 15th in dana point, ca. daniel tassÉ, chief executive officer, will engage in a fireside chat session on wednesday, june 14th at 10:00am pst (1:00pm est), as well as one-on-one investor meetings throughout the day.
DBVT Ratings Summary
DBVT Quant Ranking